PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35176943-11	2022	RAD51 expression was reduced by the ATM/ATR pathway inhibitor AZ20.	AZ20	62-66	ATR serine/threonine kinase	Homo sapiens	40-43	
28440428-5	2017	In the present study, we tested the antitumor activity of AZ20, a novel ATR-selective inhibitor, alone or combined with GEM in 5 pancreatic cancer cell lines.	AZ20	58-62	ATR serine/threonine kinase	Homo sapiens	72-75	
28176818-3	2017	Treatment with the ATR-selective inhibitor AZ20 caused proliferation inhibition in AML cell lines and primary patient samples.	AZ20	43-47	ATR serine/threonine kinase	Homo sapiens	19-22	
23394205-0	2013	Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.	AZ20	13-106	ATR serine/threonine kinase	Homo sapiens	151-154	
23394205-0	2013	Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.	AZ20	108-112	ATR serine/threonine kinase	Homo sapiens	151-154